Daiichi Sankyo

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Daiichi Sankyo and other ETFs, options, and stocks.

About DSNKY

Daiichi Sankyo Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceuticals. Its products include drugs for the field of oncology such as Trastuzumab deruxtecan, Anti-HER3-ADC, Quizartinib, Milademetan, Valemetostat, Pexidartinib, Edoxaban, Prasugel, and Microgabalin.

CEO

Hiroyuki Okuzawa

CEOHiroyuki Okuzawa

Employees

19,765

Employees19,765

Headquarters

Tokyo, Tokyo

HeadquartersTokyo, Tokyo

Founded

2005

Founded2005

Employees

19,765

Employees19,765

DSNKY Key Statistics

Market cap

40.23B

Market cap40.23B

Price-Earnings ratio

21.28

Price-Earnings ratio21.28

Dividend yield

1.81%

Dividend yield1.81%

Average volume

442.58K

Average volume442.58K

High today

$21.31

High today$21.31

Low today

$21.01

Low today$21.01

Open price

$21.01

Open price$21.01

Volume

25.67K

Volume25.67K

52 Week high

$29.68

52 Week high$29.68

52 Week low

$20.51

52 Week low$20.51

DSNKY News

TipRanks 7h

Daiichi Sankyo and Merck Advance Novel ADC Combo in Tough-to-Treat Lung Cancer

Daiichi Sankyo Company (DSKYF) announced an update on their ongoing clinical study. Claim 70% Off TipRanks This Holiday Season Daiichi Sankyo and Merck Launch...

Simply Wall St 6d

Daiichi Sankyo Company Will Pay A Dividend Of ¥39.00 - simplywall.st

...